share_log
Reuters ·  2024/10/11 04:08

Heron Therapeutics Reaffirms Availability and Ample Supply of Cinvanti®, Sustol®, and Aponvie® as Alternatives During the Potential Shortage of Intravenous Fluids

heron therapeutics重申Cinvanti®、Sustol®和Aponvie®等作爲靜脈注射液潛在短缺期間的備選品可供充足

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論